The Glenn T. Seaborg Award for Nuclear Chemistry recognizes and encourages research in nuclear and radiochemistry or their applications. Nominees must have made outstanding contributions to nuclear or radiochemistry or to their applications. The award will be granted regardless of race, gender, age, religion, ethnicity, nationality, sexual orientation, gender expression, gender identity, presence of disabilities, and educational background.
Seaborg Award Recipients
Henry VanBrocklin
Education: BS, Chemistry, and MS, Chemistry, Rensselaer Polytechnic Institute; PhD, Radiopharmaceutical Chemistry, Washington University in St. Louis
VanBrocklin on a memorable project: “I have two. The first is the development of radiolabeled fluoroestradiol analogs for breast cancer diagnostic imaging, a project that launched my career in radiopharmaceutical chemistry. The second, more recent, project is preparing radiolabeled agents to detect reservoirs of and immunological response to infectious diseases, notably HIV and COVID, to enable curative strategies.”
What VanBrocklin’s colleagues say: “Henry is a visionary scientist who has developed creative innovative approaches for the radiochemistry of new molecular imaging agents. His work is far reaching and impacts multiple disease states including Alzheimer’s disease, cancer, and HIV.”— Suzanne E. Lapi, University of Alabama at Birmingham